Drug-responsive symptoms in melancholia

Area of Science:

• Clinical Psychiatry
• Pharmacology
• Psychopharmacology

Background:

• Unipolar nondelusional melancholia is a significant subtype of depression.
• Identifying reliable measures of treatment response is crucial for effective psychopharmacological interventions.
• Desipramine hydrochloride is a commonly used tricyclic antidepressant.

Purpose of the Study:

• To determine which depressive symptoms are the most sensitive indicators of response to desipramine hydrochloride treatment.
• To establish reliable symptom measures for assessing therapeutic outcomes in melancholic depression.

Main Methods:

• Utilized an extended Hamilton Depression Scale to assess symptoms in 43 patients with unipolar nondelusional melancholia.
• Employed multiple regression analysis to correlate symptom improvement with therapeutic plasma desipramine concentrations, controlling for baseline severity.
• Investigated the direct relationship between symptom changes and achieved drug levels.

Main Results:

• Ten specific depressive symptoms showed a significant association with desipramine treatment response.
• Improvement in these ten symptoms was directly related to achieving therapeutic plasma concentrations of desipramine.
• Multiple regression analysis confirmed the significance of these symptom improvements.

Conclusions:

• The identified ten symptoms are the most effective measures for assessing desipramine response in patients with nondelusional melancholia.
• These findings can guide clinicians in monitoring treatment efficacy during tricyclic antidepressant therapy.
• This research refines the understanding of symptom-based response assessment in melancholic depression.